New Study Aims to Improve Early Lung Cancer Detection for High-Risk Hodgkin Lymphoma Survivors

Strategic Insights -

Researchers at the University of Manchester have launched a new study aimed at improving early detection of lung cancer in high-risk Hodgkin lymphoma survivors. The study, funded by a £1.3 million grant, will use an innovative lung cancer risk assessment tool and an adapted care pathway to screen 500 Hodgkin lymphoma survivors over two years. The study hopes to detect early lung cancer in an estimated 10-12 people and save lives.

Key Takeaways:

  • The new study will screen 500 Hodgkin lymphoma survivors over two years, using an innovative lung cancer risk assessment tool and an adapted care pathway.
  • The study aims to detect early lung cancer in an estimated 10-12 people and save lives.
  • Hodgkin lymphoma survivors are six times more likely to develop lung cancer than the general population.
  • The study will have an embedded program to identify and tackle health inequalities, including people with lower socioeconomic status, men, and older people.
  • Screening will take place at convenient community-based settings, including mobile clinics at supermarket car parks.
  • Researchers will actively promote screening participation for people with the highest smoking prevalence.
  • Participants will be offered health education and stop-smoking advice to encourage supported self-management to prevent lung cancer, cardiovascular disease, and other significant illnesses.
  • The study is part of the NIHR Manchester BRC's Living with and Beyond Cancer Theme, which aims to transform the detection of cancer recurrence and second cancers to improve quality of life and treatment outcomes for survivors.
  • Researchers will also collaborate with the NIHR Manchester BRC's Cancer Prevention and Early Detection Theme, which aims to reduce cancer burden across society through implementing prevention and early detection strategies.

Statistics:

  • 2,100 people in the UK are diagnosed with Hodgkin lymphoma every year (Source: National Cancer Registry, UK National Health Service).
  • Survivors of Hodgkin lymphoma are six times more likely to develop lung cancer than the general population.
  • The study will screen 500 Hodgkin lymphoma survivors over two years.
  • The study aims to detect early lung cancer in an estimated 10-12 people.
  • 1 in 10 Hodgkin lymphoma survivors will develop lung cancer within 10 years of treatment (Source: Lymphoma Action).
  • The study will have an embedded program to identify and tackle health inequalities, including people with lower socioeconomic status, men, and older people.

Sources:

  • University of Manchester (2022) - https://www.manchester.ac.uk/about/news/new-study-could-improve-early-lung-cancer-detection-for-hodgkin-lymphoma-survivors/
  • National Cancer Registry, UK National Health Service (2022) - https://www.nhs.uk/conditions/hodgkin-lymphoma/
  • Lymphoma Action (2022) - https://www.lymphoma-action.org.uk/about-lymphoma/lymphoma-statistics/